0001486189-24-000001.txt : 20240102
0001486189-24-000001.hdr.sgml : 20240102
20240102174027
ACCESSION NUMBER: 0001486189-24-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lau Stanley K.
CENTRAL INDEX KEY: 0001950824
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41097
FILM NUMBER: 24503681
MAIL ADDRESS:
STREET 1: C/O CARDIO DIAGNOSTICS HOLDINGS INC.
STREET 2: 400 N. ABERDEEN ST., SUITE 900
CITY: CHICAGO
STATE: IL
ZIP: 60642
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardio Diagnostics Holdings, Inc.
CENTRAL INDEX KEY: 0001870144
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870925574
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 W. SUPERIOR STREET
STREET 2: SUITE 444
CITY: CHICAGO
STATE: IL
ZIP: 60645
BUSINESS PHONE: 855-226-9991
MAIL ADDRESS:
STREET 1: 311 W. SUPERIOR STREET
STREET 2: SUITE 444
CITY: CHICAGO
STATE: IL
ZIP: 60645
FORMER COMPANY:
FORMER CONFORMED NAME: Mana Capital Acquisition Corp.
DATE OF NAME CHANGE: 20210629
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2023-12-31
0
0001870144
Cardio Diagnostics Holdings, Inc.
CDIO
0001950824
Lau Stanley K.
C/O CARDIO DIAGNOSTICS HOLDINGS INC.
311 W. SUPERIOR ST. SUITE 444
CHICAGO
IL
60654
1
0
0
0
0
Common Stock
2023-12-31
4
M
0
1606
2.49
A
85585
D
Common Stock
2023-12-31
4
M
0
5020
2.49
A
90605
D
Restricted Stock Units
0
2023-12-31
4
M
0
4000
0
D
2023-12-31
2024-01-31
Common Stock
4000
2000
D
Restricted Stock Units
0
2023-12-31
4
M
0
12500
0
D
2023-12-31
2023-12-31
Common Stock
12500
0
D
Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on December 31, 2023 through the issuance of shares of Common Stock.
Represents the settlement of RSUs, awarded as director compensation, which vested on December 31, 2023 through the issuance of shares of Common Stock.
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $14,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $4,000 in value of which vested on December 31, 2023. Subject to continued service with the Issuer on the vesting date, $2,000 in value of RSUs will vest on January 31, 2024.
On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on December 31, 2023.
The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.
/s/ Elisa Luqman as attorney-in-fact for Stanley Lau
2024-01-02